A New Frontier in the Co-Management of Thyroid Eye Disease

Auteur(s): Annenberg Center for Health Sciences
Écouter gratuitement

  • Résumé

  • Thyroid eye disease, also known as Graves’ orbitopathy, is a potentially serious, progressive autoimmune disease that most often occurs in people with hyperthyroidism, ie, Graves’ disease. Kimberley Cockerham, MD, FACS, moderates this series of six, paired conversations between endocrinologist Terry J. Smith, MD, and eye specialists Wendy W. Lee, MD, and Raymond Douglas, MD, PhD, to explore current and emerging treatment options for thyroid eye disease. In these conversations, faculty review the current understanding of the burden and pathophysiology of thyroid eye disease—including treatment
    Annenberg Center for Health Sciences
    Voir plus Voir moins
Hygiene & Healthy Living Troubles et maladies
Voir plus Voir moins
Épisodes
  • Radiation, Surgery

    Radiation, Surgery
    Sep 24 2021
    • The role for external beam radiation and orbital decompression in treating patients with thyroid eye disease
    • Other surgical options for treating patients with thyroid eye disease
    Voir plus Voir moins
    13 min
  • Clinical Trials Experience

    Clinical Trials Experience
    Sep 24 2021
    • Clinical data supporting the approval of teprotumumab
    • How efficacy was assessed in the teprotumumab trials
    • Emerging therapies for patients with thyroid eye disease
    Voir plus Voir moins
    16 min
  • Treatment

    Treatment
    Sep 24 2021
    • The role of intervention in patient management
    • Therapy selection for patients with thyroid eye disease
    • Evaluating treatment responses
    Voir plus Voir moins
    15 min

Ce que les auditeurs disent de A New Frontier in the Co-Management of Thyroid Eye Disease

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.